What companies are IHE's competitors?

iShares U.S. Pharmaceuticals ETF (IHE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does IHE compare to its peers?

The peer comparison table on this page shows iShares U.S. Pharmaceuticals ETF (IHE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does IHE operate in?

iShares U.S. Pharmaceuticals ETF (IHE) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

IHE

iShares U.S. Pharmaceuticals ETF

AMEX·Asset Management · Financial Services

$101.99$1.35+1.34%

After hours·$102.36+0.36%

Market cap$790.75M·Market closed·Jul 23 8:00 PM UTC

Frequently Asked Questions About IHE

What companies are IHE's competitors?: iShares U.S. Pharmaceuticals ETF (IHE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does IHE compare to its peers?: The peer comparison table on this page shows iShares U.S. Pharmaceuticals ETF (IHE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does IHE operate in?: iShares U.S. Pharmaceuticals ETF (IHE) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

IHE

iShares U.S. Pharmaceuticals ETF

AMEX·Asset Management · Financial Services

$101.99$1.35+1.34%

After hours·$102.36+0.36%

Market cap$790.75M·Market closed·Jul 23 8:00 PM UTC

Peers


IYM	iShares U.S. Basic Materials ETF	$178.56	$785.6M
IYZ	iShares U.S. Telecommunications ETF	$40.76	$764.4M
IGE	iShares North American Natural Resources ETF	$60.28	$718.8M
WCMI	First Trust WCM International Equity ETF	$19.20	$671.8M
BKMC	BNY Mellon US Mid Cap Core Equity ETF	$40.30	$668.0M
DWM	WisdomTree International Equity Fund	$73.89	$666.9M
PPH	VanEck Pharmaceutical ETF	$108.62	$641.4M
INDY	iShares India 50 ETF	$42.53	$549.9M
REM	iShares Mortgage Real Estate ETF	$21.74	$544.4M
KSA	iShares MSCI Saudi Arabia ETF	$37.12	$532.7M

Frequently Asked Questions About IHE

What companies are IHE's competitors?: iShares U.S. Pharmaceuticals ETF (IHE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does IHE compare to its peers?: The peer comparison table on this page shows iShares U.S. Pharmaceuticals ETF (IHE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does IHE operate in?: iShares U.S. Pharmaceuticals ETF (IHE) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.